MET and lung cancer: In particular, CAF-derived HGF mediates intrinsic resistance to afatinib in lung cancer by activating the MET/PI3K/AKT and MET/MAPK/ERK signaling pathways and triggering the progression of EMT and, chemoresistance development [106].